Publications:

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation.

Cell Death & Disease

Chen, Xiaohua X; Zhang, Taotao T; Su, Wei W; Dou, Zhihui Z; Zhao, Dapeng D; Jin, Xiaodong X; Lei, Huiwen H; Wang, Jing J; Xie, Xiaodong X; Cheng, Bo B; Li, Qiang Q; Zhang, Hong H; Di, Cuixia C

Publication Date: 2022-11-18

Variant appearance in text: VEGF: A135V

PubMed Link: 36400749

Variant Present in the following documents:

• Main text
• 41419_2022_Article_5408.pdf

View BVdb publication page

Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.

Pharmaceuticals (Basel, Switzerland)

Gangwar, Shailendra Kumar SK; Kumar, Aviral A; Yap, Kenneth Chun-Hong KC; Jose, Sandra S; Parama, Dey D; Sethi, Gautam G; Kumar, Alan Prem AP; Kunnumakkara, Ajaikumar B AB

Publication Date: 2022-05-18

Variant appearance in text: VEGF: Ala135Val

PubMed Link: 35631448

Variant Present in the following documents:

• Main text
• pharmaceuticals-15-00624.pdf

View BVdb publication page

Mutant p53 as a guardian of the cancer cell.

Cell Death And Differentiation

Mantovani, Fiamma F; Collavin, Licio L; Del Sal, Giannino G

Publication Date: 2019-01

Variant appearance in text: VEGF: A135V

PubMed Link: 30538286

Variant Present in the following documents:

• Main text
• 41418_2018_Article_246.pdf

View BVdb publication page

Mdm2 and MdmX as Regulators of Gene Expression.

Genes & Cancer

Biderman, Lynn L; Manley, James L JL; Prives, Carol C

Publication Date: 2012-03

Variant appearance in text: VEGF: A135V

PubMed Link: 23150759

Variant Present in the following documents:

• Main text

View BVdb publication page